Plain-English translation of NCT06562543 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing a medication called to see how well it works and how safe it is for Black and Hispanic patients with advanced colorectal cancer that has stopped responding to standard treatments. We know can raise blood pressure, but we don't yet know if this side effect happens more often or more severely in Black and Hispanic patients. This study will help answer that important question.
Most research on has not included enough Black and Hispanic patients, so doctors don't have clear information about how this treatment works specifically for these communities. This trial aims to fill that gap and make sure all patients have access to accurate safety and effectiveness information for their own care.
You likely qualify if…
You likely don't qualify if…
You will take the medication by mouth once daily for 21 days out of every 28-day cycle, continuing as long as the treatment is working and you are tolerating it well. You will have regular check-ups and blood tests to monitor how you're responding and watch for side effects, especially high blood pressure. After you stop taking the medication, you'll be checked on every 3 months until the study ends to see how you're doing.
AI-generated summary from trial data · Jul 8, 2026 · Not medical advice
United States